Introduction {#s01}
============

The transport proteins for norepinephrine (SLC6A2), dopamine (SLC6A3), and serotonin (5-hydroxy-tryptamine \[5-HT\] and SLC6A4) terminate synaptic monoamine transmission by uptake of their cognate substrates into the presynaptic specialization ([@bib23]). These proteins are secondary active transporters; substrate uptake is coupled to the electrochemical gradient of Na^+^. Under physiological conditions, this vectorial, concentrative substrate uptake prevails; the transporter, which operates by an alternating access mechanism, binds the substrate and the cosubstrate ions in the outward-facing conformation, forms an occluded state, and opens an inner gate to produce the inward-facing state, which releases substrates and cosubstrates into the cytosol. The transporter completes the catalytic cycle by isomerization from the inward-facing to the outward-facing conformation in an empty state or by antiport of K^+^ or H^+^ ([@bib30]; [@bib19]). This has been referred to as forward-transport mode. In serotonin transporters (SERTs), intracellular K^+^ and Na^+^ have been shown to play opposing roles ([@bib14]); intracellular K^+^ pushes the catalytic cycle into the forward-transport mode. In contrast, intracellular Na^+^ biases the system toward a second, distinct, transport mode. In this substrate-exchange mode, SERT oscillates between the substrate-loaded outward-facing and inward-facing conformations, but does not visit the conformations required to complete the catalytic cycle ([@bib42]). The actions of amphetamines are thought to rely on this second transport mode; amphetamines are substrates and are hence transported into the cytosol, where they are exchanged for the physiological monoamine, which is translocated to the extracellular side. Thus, under the influence of amphetamines, the monoamine transporters shuttle through half cycles and support monoamine efflux, which accounts for most, if not all, of their biological actions ([@bib42]).

Elevation of intracellular Na^+^ plays an important role in promoting the substrate-exchange mode by imposing a brake on the forward-transport cycle ([@bib14]). In both dopamine transporters (DATs; [@bib9]) and SERT ([@bib14]), this has been adequately accounted for by sequential binding of substrate and Na^+^. In a sequential order based on the first on/first off principle, Na^+^ must bind first to the outward open state of the transporter before substrate binding and also be released before the translocated monoamine/amphetamine from the inward open state of the transporter. This is also consistent with molecular dynamics simulations, which indicate that Na^+^ release from the inward-facing conformation is the first dissociation event ([@bib33]). However, sequential binding is incompatible with the action of amphetamines; elevation of intracellular Na^+^ by ouabain ([@bib4]), by the Na^+^/H^+^ ionophore monensin ([@bib40]), or via the patch pipette ([@bib21]; [@bib17]) enhances amphetamine-induced monoamine release. This can only be explained by a random order of substrate and Na^+^ binding. This is because, in a sequential binding order, raising the intracellular Na^+^ concentration ought to impede the dissociation of translocated amphetamine and thus blunt its monoamine-releasing action. This raises the question of whether amphetamines induce monoamine release by relying on the same conformational transitions observed under physiological conditions or by mechanisms distinct from alternating access (such as a substrate-conducting pore; [@bib17]). We reasoned that the action of amphetamines could be explained without assuming any additional transport modes if the binding of substrate and Na^+^ was random but cooperative; that is, Na^+^ binding increases the affinity of the substrate and vice versa. This cooperative-binding model allows for the exchange of amphetamine and 5-HT on the inward-facing state of SERT even at high internal Na^+^ concentrations while accounting for all the other observed physiological functions of SERT. We explored this model by relying on time-resolved measurements by patch-clamp recordings of specific conformational transitions induced by 5-HT and different amphetamines. We determined the effects of Na^+^ and K^+^ on the dissociation rates of different SERT substrates: 5-HT, *para*-chloroamphetamine (*p*-chloroamphetamine), the high-affinity partial releaser PAL-1045, and its congeners, PAL-287 and PAL-1046. Our observations are compatible with the assumption of cooperative binding in which Na^+^ and substrate mutually enhance their affinity for the transporter to form a ternary complex. In addition, our data suggest that the binding of K^+^ promotes substrate dissociation. A cooperative binding model was derived that recapitulated the present data in addition to a wide array of previously published results on physiological SERT function. We then tested whether this model was sufficient to explain amphetamine-induced substrate release. The model accounted qualitatively and quantitatively for the releasing action of amphetamines. Importantly, the model also provided an explanation for the phenomenon of partial release (i.e., the observation that some amphetamines are less efficacious than others in inducing monoamine efflux).

Materials and methods {#s02}
=====================

Whole-cell patch clamp {#s03}
----------------------

Patch-clamp recordings were performed with human embryonic kidney (HEK293) cells expressing human SERT carrying an N-terminal green fluorescent protein tag under the control of a tetracycline-inducible expression system. Cells were seeded at low density for 24 h before the experiments. Substrate-induced human SERT currents were recorded under voltage-clamp conditions using the whole-cell patch-clamp technique.

Unless otherwise stated, the cells were continuously superfused with external solution containing 140 mM NaCl, 2.5 mM CaCl~2~, 2 mM MgCl~2,~ 20 mM glucose, and 10 mM HEPES adjusted to pH 7.4 with NaOH (subsequently referred to as solution 1). In the experiments shown in [Fig. 1](#fig1){ref-type="fig"}, external Na^+^ concentrations were varied by mixing a Na^+^-free external solution (made by replacing 140 mM NaCl in external solution 1 with 140 mM NMDG chloride; pH was adjusted to 7.4 with NMDG) with the appropriate amount of solution 1. Variable external K^+^ concentrations shown in [Fig. 4](#fig4){ref-type="fig"} were made by adjusting NaCl, KCl, and NMDG chloride appropriately to match the concentrations displayed in the figure; constant osmolarity was maintained by using NMDG chloride.

![**Peak current recovery as a function of extracellular Na^+^ concentration. (A)** Top: Schematic rendering of the recording conditions indicating the concentrations of intracellular and extracellular substrate and cosubstrate ions and reaction scheme of a Na^+^-coupled transporter. Bottom: Original traces of representative experiments using 20, 70, or 140 mM extracellular Na^+^. **(B--F)** Time-dependent recovery of 5-HT--induced (10 µM) peak current amplitude after application of 30 µM PAL-287 (B; *n* = 5), 30 µM PAL-1046 (C; *n* = 5), 30 µM PAL-1045 (D; *n* = 5), 10 µM 5-HT (E; *n* = 5), and 30 µM *p-*chloroamphetamine (F; *n* = 5). Data are means ± SD. The data points were fitted by monoexponential functions in the case of 5-HT and the PAL substrates. A biexponential function was used to fit the recovery data of *p*-chloroamphetamine. The insets in B and C show a magnified view of the data points and fits near to the respective time constants, which are indicated by the dashed lines. **(G)** Relaxation rates were obtained by the fits from B--F. The rates shown for *p*-chloroamphetamine are the *k~fas~*~t~ values obtained from the biexponential fit. The *k~slow~* values are (±SEM) 10 mM Na^+^~e~: 0.35 ± 0.23 s^−1^; 70 mM Na^+^~e~: 0.10 ± 0.12 s^−1^; 140 mM Na^+^~e~: 0.49 ± 0.15 s^−1^. Data are means ± 95% confidence intervals of the fits. The points marked in blue were taken from a previously published study ([@bib2]). Statistical significance was determined by one-way ANOVA followed by multiple comparisons using the Fisher's LSD method. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001; n.s., not significant.](JGP_201711915_Fig1){#fig1}

Pipette solutions were prepared as described previously ([@bib14]; [@bib2]). The Na^+^- and K^+^-free pipette solution contained 143.5 mM Cl^−^, 10 mM HEPES, 1 mM CaCl~2~, 0.7 mM MgCl~2~, 10 mM EGTA, and 140 mM NMDG chloride titrated to a pH of 7.2 using NMDG. A (high) Cl^−^ concentration of 143.5 mM was chosen for the experiments shown in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} for two reasons. First, high internal Cl^−^ concentrations provided more stable recording conditions than low Cl^−^ concentrations when K^+^ was omitted. Second, and more importantly, Cl^−^ and Na^+^ have synergistic effects on ligand affinity, the extent of which varies with ligand identity ([@bib16]). Thus, studying the effect of Na^+^ on substrate binding requires saturating Cl^−^ concentrations. The concentration of Na^+^ was varied, and osmolarity was kept constant by adjusting the concentration of NMDG chloride using NaCl (e.g., 10 mM NaCl + 130 mM NMDG chloride). For experiments using a high K^+^ concentration ([Fig. 3](#fig3){ref-type="fig"}), 140 mM potassium methanesulfonate and 6 mM NaCl were used (including 10 mM HEPES, 1 mM CaCl~2~, 0.7 mM MgCl~2~, and 10 mM EGTA). Variable internal K^+^ concentrations were obtained by mixing the pipette solution containing 140 mM K^+^ with a solution containing NMDG methanesulfonate and 6 mM NaCl (including 10 mM HEPES, 1 mM CaCl~2~, 0.7 mM MgCl~2~, and 10 mM EGTA).

![**Peak current recovery as a function of intracellular Na^+^ concentration. (A)** Top: Schematic rendering of the recording conditions indicating the concentrations of intracellular and extracellular substrate and cosubstrate ions and reaction scheme of a Na^+^-coupled transporter. Bottom: Original traces of representative experiments using 10, 70, or 140 mM intracellular Na^+^. **(B--F)** Time-dependent recovery of 5-HT--induced (10 µM) peak current amplitude after application of 30 µM PAL-287 (B; *n* = 4--6), 30 µM PAL-1046 (C; *n* = 5--7), 30 µM PAL-1045 (D; *n* = 5), 10 µM 5-HT (E; *n* = 5), and 30 µM *p*-chloroamphetamine (F; *n* = 5). The red curves in B--D are the fits of data displayed in [Fig. 1](#fig1){ref-type="fig"}. Data are means ± SD. The data points were fitted by monoexponential functions in the case of 5-HT and the PAL substrates. A biexponential function was used to fit the recovery data of *p*-chloroamphetamine at 70 and 140 mM Na^+^~i~. For the Na^+^~i~-free condition, a monoexponential fit was used. **(G)** Relaxation rates were obtained by the fits from B--F. The rates shown for *p*-chloroamphetamine are the *k~fas~*~t~ values obtained from the biexponential fit. The *k~slow~* values are (±SEM) 70 mM Na^+^~i~: 0.50 ± 0.11 s^−1^; 140 mM Na^+^~i~: 0.49 ± 0.15 s^−1^. Data are means ± 95% confidence intervals of the fits. The points marked in blue were obtained from data published in a previous study ([@bib2]). The gray points displayed for 140 mM Na^+^~i~ (which equals 140 mM Na^+^~e~) were taken from [Fig. 1](#fig1){ref-type="fig"} for comparison. Statistical significance was determined by one-way ANOVA followed by multiple comparisons using the Fisher's LSD method or by an unpaired *t* test in the case of 5-HT and *p*-chloroamphetamine. \*\*\*\*, P \< 0.0001; n.s., not significant.](JGP_201711915_Fig2){#fig2}

![**Internal 5-HT binding as a function of intracellular K^+^ concentrations.** Scheme: Representation of the recording conditions indicating the concentrations of intracellular and extracellular substrate and cosubstrate ions. **(A--C)** Top: Original traces of representative experiments at intracellular K^+^ concentrations of 140 (A), 70 (B), and 35 mM (C). Bottom: Corresponding quantification of steady-state current amplitudes induced by 10 µM 5-HT. Data are means ± SD (*n* = 5--11). The solid lines were drawn by fitting the data to a rectangular hyperbola.](JGP_201711915_Fig3){#fig3}

Currents were recorded at room temperature (20--24°C) using an Axopatch 200B amplifier and pClamp 10.2 software (MDS Analytical Technologies). Current traces were filtered at 1 kHz and digitized at 2 kHz using a Digidata 1320A (MDS Analytical Technologies). Drugs were applied using a DAD-12 (ALA Scientific Instruments), which allows for rapid solution exchange ([@bib38]; [@bib14]). Current amplitudes in response to 5-HT application were quantified using Clampfit 10.2 software (Molecular Devices). Passive holding currents were subtracted, and the traces were filtered using a 100-Hz digital Gaussian low-pass filter.

Release experiments {#s04}
-------------------

Outwardly directed transport flux assays were performed as described previously ([@bib40]; [@bib27]). In brief, HEK293 cells expressing human SERT carrying an N-terminal green fluorescent protein tag under the control of a tetracycline-inducible expression system were seeded 24 h before the release assay onto poly-[d]{.smallcaps}-lysine--coated glass coverslips (5-mm diameter, 40,000 cells per coverslip). Preloading of the cells with tritiated substrate was ensured by exposing the cells to 0.1 µM \[^3^H\]MPP^+^ for 20 min at 37°C. Subsequently, the cells were transferred into small chambers (total volume of 200 µl) and superfused with K^+^-free buffer (flow rate of 0.7 ml per min) containing 100 µM ouabain for 40 min to establish a basal release. After 40 min, the collection of 2-min fractions was initiated. After three basal fractions, the cells were exposed to either 10 µM monensin or solvent (ethanol, 96%) for four fractions before 3 µM *p*-chloroamphetamine or PAL1045, respectively, was added for another five fractions. Finally, the cells were superfused with SDS (1%) for three fractions. The total amount of tritium within the superfusates was determined by use of a β-scintillation counter. The amount of \[^3^H\]MPP^+^ released per fraction was expressed as a fractional rate (i.e., the percentage of the total amount of radioactivity present at the beginning of that fraction; [@bib43]).

Statistics {#s05}
----------

Experimental variations are either reported as means ± 95% confidence intervals, means ± SD, or means ± SEM.

Peak current recovery data were fitted to the equation describing a monoexponential rise to a maximum. The data generated with *p*-chloroamphetamine were better described by a biexponential rise to a maximum (i.e., the sum of two exponential processes). We attribute the slow component of the recovery to back diffusion of *p*-chloroamphetamine from the cell lumen ([@bib36]). This diffusion does not affect recovery rates in the case of the PAL substrates because of their slow dissociation rates ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}; [@bib2]). Significant differences in peak current recovery rates ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) were determined by one-way ANOVA followed by multiple comparisons using the Fisher's least significant difference (LSD) method. In the case of *p*-choloroamphetamine and 5-HT in [Fig. 2](#fig2){ref-type="fig"}, unpaired *t* tests were used. Data from concentration--response curves were fitted to a rectangular hyperbola to obtain estimates for *EC~50~* and maximum transport or efflux.

Modeling {#s06}
--------

The cooperative binding model of SERT was developed based on a published sequential binding model ([@bib38]; [@bib14]). The evolution of state occupancies was computed by numerical integration of the resulting system of differential equations using the Systems Biology Toolbox ([@bib39]) and MATLAB 2017a software (Mathworks). The voltage dependence of individual partial reactions was modeled according to [@bib24] assuming a symmetric barrier as$$k_{ij} = {k^{0}}_{ij}e^{- z{Qij}FV/2RT},$$where *F* = 96,485 C·mol^−1^, *R* = 8.314 JK^−1^mol^−1^, *V* is the membrane voltage in volts, and *T* = 293 K. Coupled membrane currents upon application of substrate were calculated as$$I = - F \times NC/N_{A} \times \Sigma z_{Qij}\left( p_{i}k_{ij} - p_{j}k_{ji} \right),$$where *z*~Qij~ is the net charge transferred during the transition, *NC* is the number of transporters (4 × 10^6^/cell), and *N*~A~ = 6.022e^23^/mol. The substrate-induced uncoupled current was modeled as a current through a Na^+^-permeable channel with$$I = P_{c}\gamma NC\left( {V - V_{rev}} \right),$$where *P*~c~ corresponds to the occupancy of the channel state, γ is the single-channel conductance of 2.4 pS, *NC* is the number of transporters (4 × 10^6^/cell), *V* is the membrane voltage, and *V*~rev~ is the reversal potential of Na^+^ (80 mV). The extracellular and intracellular ion concentrations were set to the values used in the respective experiments. To account for the noninstantaneous onset of the substrate in patch-clamp experiments, we modeled the substrate application as an exponential rise with a time constant of 10 ms.

Peak current recovery after substrate application ([Figs. 5](#fig5){ref-type="fig"}, [A2](#figA2){ref-type="fig"}, and [A4](#figA4){ref-type="fig"}) was modeled as the time-dependent return of the system to ToClNa ([Fig. 5 A](#fig5){ref-type="fig"}). Substrate release was modeled as time-dependent substrate dissociation from ToClNaS, ToClKS, and ToClS ([Fig. 5 A](#fig5){ref-type="fig"}) multiplied by *NC* and divided by *N~A~* (see above). Conversely, substrate uptake ([Fig. A3](#figA3){ref-type="fig"}) was modeled as substrate dissociation from TiClNaS, TiClKS, and TiClS ([Fig. 5 A](#fig5){ref-type="fig"}) multiplied by *NC* and divided by *N~A~* and normalized to the maximal uptake. Displacement of imipramine binding ([Fig. A3](#figA3){ref-type="fig"}) was simulated as substrate concentration--dependent occupancy of an inhibitor-bound state. The inhibitor (rates shown in figure legend) was modeled to bind to ToClNa (not depicted in [Fig. 5 A](#fig5){ref-type="fig"}).

Results {#s07}
=======

We investigated whether cooperative binding provided a unifying explanation for the forward-transport mode of monoamine transporters and the releasing action of amphetamines by addressing the following questions. (a) Do substrate and Na^+^ bind to SERT in a cooperative manner? (b) Does K^+^ binding, which promotes forward transport, oppose the effect of Na^+^ binding by decreasing substrate affinity? (c) Can a parsimonious cooperative binding model account for the releasing action of amphetamines, or are additional transport modes required? (d) Can the model predict the dependence of substrate release on the intracellular concentration of Na^+^ and on the identity of an amphetamine-like congener?

Dependence of substrate dissociation on intracellular and extracellular Na^+^ concentration {#s08}
-------------------------------------------------------------------------------------------

We tested whether the binding of substrate and of Na^+^ to SERT (both extracellularly and intracellularly) was cooperative. We reasoned that the time course over which substrates dissociate from the transporter as a function of intracellular and extracellular Na^+^ concentrations should provide insights into the mechanism of interaction between substrate and Na^+^. To this end, we recorded SERT-mediated currents in HEK293 cells using whole-cell patch-clamp recordings; these allowed us to control both extracellular (through the bath solution) and intracellular (through the patch pipette) ionic concentrations (see Materials and methods). Currents carried through SERT under physiological ion gradients (high extracellular Na^+^ and high intracellular K^+^ concentrations) consist of two components ([@bib38]; [@bib14]): (1) an initial and transient peak current, which reflects the movement of substrate and Na^+^ through the membrane electric field; its amplitude is proportional to the number of transporters residing in an outward-facing, substrate-free state, and (2) a steady-state current that persists during substrate application; this current requires internal K^+^ and is a readout of the forward-transport mode of the transporter. These two currents therefore reflect distinct partial reactions in the transport cycle of SERT and are dependent on the used cosubstrate gradients. Substrate-induced currents through SERT are thus useful signals to track the conformational transitions of this protein with high temporal resolution. We examined the interaction of intracellular and extracellular Na^+^ with five different substrates: 5-HT, *p*-chloroamphetamine, and the naphthyl-propan-amines PAL-287, PAL-1045, and PAL-1046 to SERT. The latter three compounds are atypical releasers ([@bib35]), which have been shown to display slow dissociation kinetics ([@bib2]). These substrates are thus ideally suited to study the effect of Na^+^ on the stability of the substrate--transporter complex. For instance, their slow dissociation rates from the outward-facing conformation should not change with increasing external Na^+^ concentrations if a sequential order is assumed; yet, these off-rates are predicted to decrease if substrate and Na^+^ binding is cooperative. We investigated the effect of Na^+^ on substrate binding to SERT by relying on external and internal K^+^-free solutions, which contained Na^+^ concentrations ranging from 10 to 140 mM (see Materials and methods). Depleting intracellular K^+^ isolates the peak component of the substrate-induced current by eliminating the steady-state component. In the absence of intracellular K^+^, the transporter still operates in the forward-transport mode, albeit at a substantially slower rate ([@bib14]; [@bib2]). Conversely, increasing the intracellular Na^+^ concentration supports the substrate-exchange mode ([@bib14]). In this mode, the transporter does not complete the catalytic cycle; instead, it returns to the outward-facing conformation loaded with substrate. The recovery of the transporters from a substrate-loaded to a substrate-free species via these distinct transport modes was quantified using a previously described ([@bib9]; [@bib14]; [@bib2]) peak current recovery protocol ([Figs. 1 A](#fig1){ref-type="fig"} and [2 A](#fig2){ref-type="fig"}). In this protocol, substrate binding generates a peak current; its amplitude serves as a reference for the number of transporters available for substrate binding in the recorded cell. Reapplication of the substrate after a defined wash time generates another peak current; the amplitude of this current is contingent on the number of binding sites, which have released their cognate substrate in the interval between original reference pulse and test pulse. Repeated substrate application at increasing wash time intervals tracks the recovery of substrate-binding sites to 100%. At 100% recovery, the amplitudes of the reference peak and the test peak currents are similar, indicating complete dissociation of all substrate molecules occupying the binding sites before application of the test pulse.

### Extracellular Na^+^ {#s09}

We first tested this recovery as a function of extracellular Na^+^ concentrations with a fixed intracellular Na^+^ concentration of 140 mM. [Fig. 1 A](#fig1){ref-type="fig"} shows current traces from three representative experiments. We applied substrate for 200 ms and tested the recovery of substrate-binding sites by applying 10 µM 5-HT. The amplitude of the 5-HT--induced peak current served as a measure of recovered outward-facing transporters ([@bib14]; [@bib2]). 5-HT was used to probe the recovered binding sites in all cases because PAL-287, PAL-1045, and PAL-1046 require very long washout times between sweeps (up to 2 min for PAL-1045 compared with 10--30 s for 5-HT). The time courses of recovery were fit to monoexponential functions to obtain estimates for the recovery rates in the case of the PAL substrates and 5-HT ([Fig. 1, B--E](#fig1){ref-type="fig"}). In the case of *p*-chloroamphetamine, a biexponential function was used because the fit was significantly improved (F test, P \< 0.0052). It is evident from [Fig. 1 G](#fig1){ref-type="fig"} that the kinetics differed significantly between substrates by up to two orders of magnitude (e.g., 0.025 ± 0.001 s^−1^ for PAL-1045 vs. 4.012 ± 0.211 s^−1^ for 5-HT). We did not detect any dependence of the recovery rates on extracellular Na^+^ concentration after 5-HT or *p*-chloroamphetamine application, which is expected because of their rapid dissociation kinetics. However, in the case of all three PAL substrates, there was a statistically significant ∼2.5-fold increase in recovery rates when extracellular Na^+^ concentrations were reduced from 140 to 10 mM. This observation is incompatible with a sequential binding order but is consistent with cooperative binding of substrate and Na^+^.

### Intracellular Na^+^ {#s10}

In a second set of experiments, we measured peak current recovery rates at varying intracellular Na^+^ concentrations but at a fixed extracellular Na^+^ concentration of 140 mM ([Fig. 2, A--F](#fig2){ref-type="fig"}). We found that Na^+^ had differential effects on these rates ([Fig. 2 G](#fig2){ref-type="fig"}). In the case of 5-HT and *p*-chloroamphetamine, the rates of peak current recovery increased in the tested range of intracellular Na^+^ concentrations (0 M to 140 mM intracellular Na^+^) by ∼6.7-fold and 10-fold, respectively. These changes in recovery rates have been attributed to the Na^+^-induced switch of the transporter from the slow forward-transport mode in the absence of intracellular K^+^ to the rapid substrate-exchange mode in the presence of high intracellular Na^+^ concentrations ([@bib9]; [@bib14]; [@bib2]; [@bib18]). When PAL-287 and PAL-1046 were examined, the rates were substantially lower than those obtained with 5-HT and *p*-chloroamphetamine, but they did not change with Na^+^ concentration. However, for PAL-1045, the rate of recovery decreased fourfold with increasing Na*^+^* between 0 and 140 mM Na^+^. These data suggested that the affinity of these substrates increased with Na^+^ concentrations (more specifically PAL-1045), which suggested cooperative binding. Importantly, individual substrates differed in the extent to which their affinity was modulated by Na^+^, indicating that the degree of this cooperativity was substrate dependent.

Destabilization of the substrate--transporter complex by K^+^ {#s11}
-------------------------------------------------------------

It is plausible to posit that, in a cooperative binding mechanism, K^+^ opposes the action of Na^+^ and decreases substrate affinity. This possibility is supported by several observations. For instance, under physiological conditions, SERT returns to the outward-facing conformation in a K^+^-bound form ([@bib30]). This reaction is thought to be the rate-limiting step of the transport cycle ([@bib38]). In the absence of intracellular Na^+^ and K^+^, peak current recovery for all three PAL substrates was substantially slower than the corresponding rates obtained with 5-HT and *p*-chloroamphetamine ([Fig. 2](#fig2){ref-type="fig"}; [@bib2]). These data suggest that dissociation of the PAL substrates from the inward-facing conformation was rate limiting for the return to the outward-facing conformation. However, physiological intracellular K^+^ concentrations accelerated internal PAL dissociation by at least 30-fold, such that it was not rate limiting for completion of the transport cycle ([@bib2]). These findings suggest that K^+^ binding lowers substrate affinity, which may be achieved in two ways: (1) K^+^ may reduce the apparent substrate affinity simply by competing with Na^+^ for binding. This is predicted to shorten the residence time at the inward-facing conformation and to thereby lower the probability for rebinding of intracellular substrate; (2) alternatively, the substrate affinity may be directly reduced by K^+^ binding (e.g., via an increase of the substrate dissociation rate).

### Low apparent affinity of internal 5-HT in the presence of internal K^+^ {#s12}

We tested these possibilities and first measured the inhibition of steady-state currents by intracellular 5-HT ([@bib1]; [@bib14]) as a function of intracellular K^+^ concentrations. The steady-state current amplitudes decreased with increasing internal 5-HT concentrations ([Fig. 3 A](#fig3){ref-type="fig"}). Consistent with a previous study ([@bib14]), an internal 5-HT concentration of 1 mM was necessary to eliminate the steady-state current in the presence of 140 mM internal K^+^. Half-maximal inhibition of the steady-state current occurred at 158.50 µM (95% CI: 108.90--237.40 µM; r^2^ = 0.84; [Fig. 3 A](#fig3){ref-type="fig"}). This apparent affinity is approximately one order of magnitude lower than the potency of 5-HT to displace \[^3^H\]β-CIT from the outward-facing conformation ([@bib22]) and three orders of magnitude lower than the potency to induce steady-state currents ([@bib38]). These data suggest that the ionic composition (high \[K^+^\]/low \[Na^+^\]) lowers the apparent 5-HT affinity. Hence, decreasing internal K^+^ concentrations ought to increase the potency of internal 5-HT to inhibit steady-state currents. However, when intracellular K^+^ concentrations were lowered to 70 and 35 mM, there was a substantial decrease in steady-state current amplitude ([Fig. 3, B and C](#fig3){ref-type="fig"}). This precluded a reliable investigation of the effects of K^+^ on the potency of substrate-induced inhibition of the steady-state current. The unfavorable signal to noise ratio is evident from the parameter estimates (IC~50~ values: 70 mM K^+^, 186.30 µM \[95% CI: 77.97--539.00 µM; r^2^ = 0.46\], 35 mM K^+^, 233.30 µM \[95% CI: 90.96--828.20 µM; r^2^ = 0.31\]; [Fig. 3, B and C](#fig3){ref-type="fig"}).

### K^+^ enhances substrate dissociation {#s13}

Whole-cell patch-clamp recordings allow for rapid (co)substrate exchange only on the extracellular side. Hence, it is not possible to assess substrate binding to the inward-facing conformation via a time-resolved approach. Nevertheless, if K^+^ facilitates substrate dissociation from inward-facing transporters, it is plausible that it may also do so at the outward-facing conformation. We therefore resorted to an alternative approach to study the effect of K^+^ on substrate dissociation and capitalized on the slow dissociation of PAL-1045 (∼0.025 s^−1^). This slow rate provided a favorable dynamic range for detecting any acceleration of substrate dissociation by K^+^. We used recording conditions where unbinding of PAL-1045 from the inward-facing conformation was prevented by using an internal solution containing 140 mM Na^+^. We selected an external Na^+^ concentration of 35 mM; this concentration was high enough to slow down dissociation of PAL-1045 ([Fig. 1, D and G](#fig1){ref-type="fig"}) but was low enough to allow for competition of K^+^ with Na^+^ for binding to SERT. The protocol was as follows: we applied 30 µM PAL-1045 for 200 ms and tested the peak current recovery with a pulse of 100 µM 5-HT after 20 s (i.e., after the first half-life of recovery; compare with [Fig. 1 D](#fig1){ref-type="fig"}) and after 80 s (the time point where close to 100% recovery was achieved; compare with [Fig. 1 D](#fig1){ref-type="fig"}). The initial 20-s wash period after application of PAL-1045 consisted of (a) washing the cell with bath solutions containing 35 mM Na^+^ and variable K^+^ concentrations (0, 35, 70, or 105 mM) for 15 s followed by (b) reapplication of the K^+^-free solution containing 35 mM Na^+^ for 5 s before the challenge with 100 µM 5-HT. The latter was to avoid two confounding effects: (1) The presence of K^+^ bound to outward-facing SERT would not allow for peak current induction. It must therefore undergo dissociation. The binding pocket must then be refilled with Na^+^ before the substrate binds. (2) K^+^ application to a HEK293 cell is expected to elicit unspecific changes in holding current, which would confound the interpretation of the peak current (compare holding currents of [Fig. 4 A](#fig4){ref-type="fig"} without external K^+^ with [Fig. 4 B](#fig4){ref-type="fig"}, where K^+^ was applied).

![**Peak current recovery as a function of extracellular K^+^ concentrations. (A)** Original trace of a representative experiment using a K^+^-free external solution containing 35 mM Na^+^. Insets: 5-HT--induced peak currents 20 s (left) and 80 s (right) after application of 30 µM PAL-1045. The black bars indicate the 200-ms 5-HT application. **(B)** Original trace of a representative experiment using an external solution containing 35 mM Na^+^ and 70 mM K^+^. K^+^ was applied for 15 s after the PAL-1045 pulse. The external Na^+^ concentration (35 mM) was held constant throughout the recording. Inset: 5-HT--induced peak current after application of 70 mM K^+^ for 15 s and a wash period of 5 s with 35 mM Na^+^. Note the outward current component, which was not seen in the absence of prior K^+^. **(C)** Peak current traces taken from five experiments per experimental condition (the five experimental conditions are indicated on the left). The black traces represent the means of individual traces shown in gray. The black bars indicate the application of 5-HT for 200 ms. The left- and right-hand traces are 5-HT--induced currents 20 s and 80 s after PAL-1045 application, respectively.](JGP_201711915_Fig4){#fig4}

[Fig. 4 A](#fig4){ref-type="fig"} shows a representative experiment using a K^+^-free external solution. Although the cell had been washed for 20 s with a solution containing 35 mM Na^+^, the current after exposure exhibited only half of the amplitude of the control current (compare left vs. right inset in [Fig. 4 A](#fig4){ref-type="fig"}). This was consistent with the recovery experiment shown in [Fig. 1 D](#fig1){ref-type="fig"} and confirmed slow dissociation of PAL-1045 from SERT at a rate of ∼0.025 s^−1^. [Fig. 4 B](#fig4){ref-type="fig"} shows a representative experiment in which PAL-1045 was washed off with a solution containing 70 mM K^+^ in addition to 35 mM Na^+^. Although K^+^ had been removed 5 s before application of 5-HT, the shape of the 5-HT--induced current changed substantially. First, we observed an inwardly directed component, which was the result of substrate binding to the fraction of transporters in the outward-facing conformation. This was followed by an outwardly directed component, which appeared upon current relaxation ([Fig. 4 B](#fig4){ref-type="fig"}, left inset). The outwardly directed current is reminiscent of an outward current observed in DAT ([@bib9]). This current has been associated with the isomerization of the substrate-bound transporter from the inward-facing to the outward-facing conformation; it has therefore been interpreted as the mirror image of the substrate-induced inward peak current. Because substrate translocation is also electrogenic in SERT ([@bib38]; [@bib14]), an outward peak current is the expected consequence of intracellular substrate binding to transporters, which are trapped in the inward-facing conformation. This was likely the case in the present experiment for the following reasons. (a) High extracellular K^+^ concentration and high intracellular Na^+^ concentration reversed the cosubstrate gradients. These gradients are predicted to shift the conformational equilibrium toward the inward-facing conformation. Additionally, inward-facing transporters are conformationally trapped under high intracellular Na^+^ at concentrations four times higher than that seen by transporters in the outward-facing conformation. Thus, as a mirror image of the physiological transport cycle, the following rules apply: The inward-facing transporter can only translocate to the outward-facing conformation either loaded with K^+^ or with Na^+^ plus substrate. More importantly, the outward-facing K^+^-bound transporter can only translocate to the inward-facing conformation once the substrate has dissociated. (b) Extracellular application of 100 µM 5-HT has been shown to result in diffusion of 5-HT into the cell and binding to the inward-facing conformation ([@bib36]). Given the present experimental conditions, application of 100 µM 5-HT ought to result in internal binding to the transporter, leading to an outward current.

It is worth noting that K^+^ altered the current, although it had been removed 5 s before the application of 5-HT. At this time point, K^+^ must have fully dissociated from the transporter ([@bib38]; [@bib14]). In addition, the outward current elicited by 5-HT required complete dissociation of the PAL substrate because sustained binding of PAL-1045 ([@bib2]) would have precluded the accumulation of transporters in the inward-facing state (as seen in the absence of external K^+^; [Fig. 4 A](#fig4){ref-type="fig"}). Thus, the data summarized in [Fig. 4 B](#fig4){ref-type="fig"} imply that PAL-1045 dissociated from the outward open state before the removal of K^+^. The conclusion that K^+^ enhances PAL-1045 dissociation---and does not simply compete with Na^+^---was further corroborated by experiments that used only NMDG in the wash solution (i.e., no Na^+^ or K^+^ during the wash phase). These recordings did not reveal any change in the shape or amplitude of the peak current (compare the different experimental conditions in [Fig. 4 C](#fig4){ref-type="fig"}). Collectively, the data suggest that K^+^ directly decreases substrate affinity. Importantly, this implies that a ternary complex of SERT--substrate--K^+^ (in this case, SERT--PAL-1045--K^+^) exists and that K^+^ and substrate do not bind to SERT in a mutually exclusive manner.

A cooperative binding model of SERT {#s14}
-----------------------------------

Currently available transport models implicitly assume or explicitly posit sequential binding of substrates and cosubstrates ([@bib9]; [@bib38]; [@bib36]; [@bib14]), but these cannot account for the observed effect of Na^+^ or K^+^ binding on substrate affinity. Most importantly, no currently available kinetic model can quantitatively account for amphetamine action. Accordingly, we designed a kinetic model of SERT in which we replaced sequential binding by a random, but cooperative, binding order ([Fig. 5 A](#fig5){ref-type="fig"}; and see Appendix). We emphasize that the kinetic parameters were not set to specifically account for amphetamine-induced substrate release. Rather, the parameters were constrained by the findings from the electrophysiological experiments and by data from radioligand binding and uptake inhibition assays to test whether the resulting physiological transport modes would suffice to explain the releasing action of amphetamines. A detailed description of how the kinetic parameters were derived can be found in the Appendix. The central tenet of the model is that cooperative binding unites the features of sequential and random binding and should therefore account for both the physiological function of SERT and the action of amphetamines. It assumes that the affinities of Na^+^ and substrate are low when they bind alone, but that their affinities increase upon ternary complex formation. We applied this principle by using cooperativity factor *α,* which specified the extent to which formation of the ternary complex reduced the dissociation rates of substrate and Na^+^. For instance, an *α* value of 1 (i.e., no cooperativity) does not change the dissociation rates, whereas an *α* value of 10 would decrease dissociation rates by a factor of 10, thus increasing the affinity 10-fold. The model also allowed cooperativity factor *α* to differ for individual substrates while maintaining microscopic reversibility.

![**Cooperative binding model of SERT. (A)** Kinetic scheme of the model. *k~on~(S~out~)* = 10^7^ M^−1^ s^−1^ (5-HT/PAL-1045/1046/287), 2 × 10^6^ M^−1^ s^−1^ (*p*-chloroamphetamine); *k~off~(S~out~)* = 10 s^−1^ (5-HT, *p*-chloroamphetamine), 0.5 s^−1^ (PAL-1045), 15 s^−1^ (PAL-1046/287); *k~on~(S~in~)* = 10^6^ M^−1^ s^−1^ (5-HT/PAL-1046/287), 7 × 10^7^ M^−1^ s^−1^ (PAL-1045), 10^5^ M^−1^ s^−1^ (*p*-chloroamphetamine); *k~off~(S~in~)* = 1 s^−1^ (5-HT), 3.5 s^−1^ (PAL-1045), 1.5 s^−1^ (PAL-1046/287), 0.5 s^−1^ (*p*-chloroamphetamine). α values: 5-HT, 30; PAL-1045, 25; PAL-1046/287, 20; *p*-chloroamphetamine, 1. ω values: 200 for all substrates. **(B)** Simulated current traces of 30 µM 5-HT, 30 µM PAL-1045, and 30 µM *p*-chloroamphetamine. This panel reproduces experimental data described in [@bib2] and [@bib36]. **(C and D)** Simulation of Na^+^ dependence of peak current recovery at varying extracellular (C) and intracellular (D) Na^+^ concentrations. This simulation reproduces data shown in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and partly in [@bib2]. The time course of recovery after substrate application was modeled as the time course of return to ToClNa after substrate application. For the data points shown for *p*-chloroamphetamine, *k~fas~*~t~ values obtained from the biexponential fits were used (see Materials and methods).](JGP_201711915_Fig5){#fig5}

It is important to note that the cooperative binding model was designed such that it effectively behaves like a sequential binding model when physiological ion gradients are used. The dissociation rate of internal Na^+^ from the ternary complex (1,500 s^−1^ divided by *α*) is substantially higher than that of substrate (0.5--3.5 s^−1^ divided by *α*; [Fig. 5](#fig5){ref-type="fig"}); Na^+^ will thus dissociate before the substrate. Yet, it allows for substrate exchange when high internal Na^+^ concentrations are used.

### The cooperative binding model accounts for the experimental observations {#s15}

[Fig. 5 B](#fig5){ref-type="fig"} shows simulated current traces induced by 30 µM 5-HT (black trace), *p*-chloroamphetamine (blue trace), and PAL-1045 (red trace). It is evident that the model accounts for the previously described substrate-induced currents ([@bib2]). Consistent with experimental observations, the current induced by PAL-1045 decreased in amplitude during the course of substrate application and displayed a biphasic relaxation upon substrate removal (i.e., there was an initial increase in current amplitude followed by a slow decay). This complex signature of amphetamine-induced currents has previously been explained by diffusion into the cell (because of their lipophilic nature) and internal amphetamine binding to the transporter ([@bib36]). In the case of the PAL substrates, this already occurred at lower concentrations than those in the case of *p*-chloroamphetamine ([@bib2]) and was reproduced by the model. The assumption that PAL substrates display higher affinities to SERT than *p*-chloroamphetamine accounted for the different current profiles. To restrict the complexity of the model to a minimum, we did not use the previously established model for amphetamine diffusion via the cell membrane ([@bib36]). Instead, we defined the time-dependent rise in intracellular substrate concentrations as the concomitant inward (and outward) flow of substrate with a time constant of 10 ms. The diffusion of the amphetamines into the cell was required to model the bell-shaped concentration dependence of amphetamine-induced substrate release ([Fig. 6 C](#fig6){ref-type="fig"}).

We examined whether the dependence of tested substrates on intracellular and extracellular Na^+^ concentrations was accounted for by cooperative binding by simulating the peak current recovery experiment using the same conditions as those presented in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}. It is evident from [Fig. 5 (C and D)](#fig5){ref-type="fig"} that the model recapitulated the recovery rates of 5-HT, *p*-chloroamphetamine, and the PAL substrates as a function of internal and external Na^+^ concentrations. The kinetic rates used to model the binding of the PAL substrates also allowed for simulating their affinities determined in radioligand binding experiments (see Appendix; [@bib2]). Analogous to Na^+^ binding, we used a negative cooperativity factor *ω* for K^+^ binding ([Fig. 5 A](#fig5){ref-type="fig"}). This factor determined the extent to which K^+^ binding decreased substrate affinity and vice versa. For the sake of simplicity, H^+^ was modeled to bind in a sequential order, although we suspect that H^+^ ions bind in a similar fashion as K^+^.

### A kinetic account for amphetamine-induced monoamine release {#s16}

The main reason to introduce a cooperative binding model was to examine whether an alternating access model is sufficient to account quantitatively for amphetamine-induced monoamine release, or whether additional amphetamine-specific modes (such as a substrate-conducting pore) were required. We therefore simulated 5-HT release upon application of external *p*-chloroamphetamine. As shown in [Fig. 6 A](#fig6){ref-type="fig"}, the model captured increased 5-HT release with increasing intracellular Na^+^ concentrations, which is a feature that cannot be explained by a sequential binding model. The *EC~50~* value of *p*-chloroamphetamine to induce 5-HT release was ∼3 µM. It therefore matched the experimentally determined value ([@bib15]; [@bib41]). In addition, the calculated rate of *p*-chloroamphetamine--induced 5-HT release was in agreement with experimental data; the maximal release of 2 × 10^−15^ mol 5-HT within the 1-min simulation is equivalent to 2,000 pmol/10^6^ cells per minute ([@bib15]). Thus, the present kinetic model provides, to the best of our knowledge, the first qualitative and quantitative account for amphetamine-induced monoamine release.

![**Simulation of amphetamine-induced serotonin release and partial release.** Top: Schematic rendering of the steps involved in facilitated exchange diffusion. The releaser (R) binds to the outward-facing conformation, leading to isomerization of the transporter to the inward-facing conformation. Upon dissociation of the releaser, the internal substrate binds and can be released after the return of the transporter to the outward-facing conformation. Gray, red, and yellow reactions illustrate the mechanisms of partial release. Gray: A partial releaser may bind in two distinct modes, either as inhibitor (I, in gray) or releaser (R, in blue; see B). Red versus green: A partial releaser may display high affinity to the transporter; this results in a longer dwell time of the releaser in the binding site and thus less exchange between releaser and intracellular monoamine (see C). Yellow: Experimental manipulations may reduce the transition rate between the substrate-loaded outward- and inward-facing conformations; this results in reduced release (see G and H). **(A--C)** Simulation of 5-HT release by increasing concentrations of *p*-chloroamphetamine (A), MDDMA (B), or PAL-1045 (C) at different intracellular Na^+^ concentrations. The solid lines were generated by fitting the synthetic data to a rectangular hyperbola to extract *EC~50~* values and maximum release (*V~max~*). **(D and E)** *EC~50~* values (D) and *V~max~* values (E) of *p*-chloroamphetamine, MDDMA, and PAL-1045 in inducing 5-HT release as a function of the intracellular Na^+^ concentration. **(F)** Voltage dependence of 5-HT release upon application of 3 µM *p*-chloroamphetamine (approximately the *EC~50~*). The release simulations were performed as in A--E, but at voltages ranging from −150 to 150 mV. **(G)** Simulation of 5-HT release by *p*-chloroamphetamine via the N-terminal mutant hSERT-ΔN32. Simulation conditions were the same as in A--F. **(H)** Turnover rate of N-terminal mutant hSERT-ΔN32 compared with wild-type hSERT. The time course of recovery after substrate application was modeled as the time course of return to ToClNa after 5-HT application.](JGP_201711915_Fig6){#fig6}

### A mechanistic explanation for partial release {#s17}

The efficacy of amphetamine-induced monoamine release varies among substrates; in analogy to the partial agonists of receptors, substrates that display reduced *V~max~* values in inducing monoamine efflux have been referred to as partial releasers ([@bib35]). We propose that at least two mechanisms can account for partial release: First, a substrate may be less efficacious in inducing monoamine release because it binds in distinct modes to the outward-facing conformation. It has been suggested that a methylated derivative of 3,4-methylenedioxy-*N*-methylamphetamine, the partial releaser 3,4-methylenedioxy-*N*,*N*-dimethylamphetamine (MDDMA), has ∼50% of its binding events as a substrate. Alternatively, it can also bind in an inverted orientation as an inhibitor ([@bib37]). As shown in [Fig. 6 B](#fig6){ref-type="fig"}, substrate efflux induced by MDDMA can be accounted for by assuming that 50% of the compound bound as an inhibitor with the same binding kinetics as the substrate. In the second scenario for partial release, high affinity of the releaser may preclude sufficient exchange between releaser and internal substrate because the releaser displays a long dwell time at the transporter. This is likely the case for the partial releaser PAL-1045 (as shown in [Fig. 6 C](#fig6){ref-type="fig"}), which displays the highest affinity of the tested substrates. For PAL-1045, the model predicts a bell-shaped concentration--response curve for release, which is reminiscent of the currents induced by it ([@bib2]). Note that the potency to induce release differs between the two partial releasers (and *p*-chloroamphetamine): MDDMA is a low-affinity, low-efficacy releaser displaying *EC~50~* values of 1--3 µM (depending on the intracellular Na^+^ concentration; [Fig. 6 D](#fig6){ref-type="fig"}); PAL-1045, however, is a high-affinity, low-efficacy releaser with *EC~50~* values of ∼150--330 nM ([Fig. 6 D](#fig6){ref-type="fig"}). The difference in *V~max~* values for release among the substrates was dependent on internal Na^+^ concentrations; it became apparent only at Na^+^ concentrations of ≥10 mM (compare open circles and squares with open triangles and closed symbols in [Fig. 6, A--C and E](#fig6){ref-type="fig"}). However, the *EC~50~* values doubled in the case of the full releaser and the partial releasers, though their cooperativity factors differed by a factor of 25 (*p*-chloroamphetamine and MDDMA: random \[*α* value = 1\]; PAL-1045: cooperative \[*α* value = 25\]; [Fig. 6 D](#fig6){ref-type="fig"}). Amphetamine-induced dopamine release increases with membrane potential ([@bib21]; [@bib17]); in addition, intracellular Na^+^ binding to SERT is highly voltage dependent ([@bib14]). We incorporated this voltage dependence into the model ([Fig. 5 A](#fig5){ref-type="fig"} and Appendix). When we simulated 5-HT release at 3 µM *p*-chloroamphetamine at different voltages, we found an increase with membrane potential up to 50 mV. At higher voltages, we observed a decrease in 5-HT release ([Fig. 6 F](#fig6){ref-type="fig"}); this bell-shaped relationship has been observed experimentally in DAT ([@bib17]).

Truncation of the N terminus of the transporter or its tethering ([@bib47]; [@bib18]), depletion of membrane lipids ([@bib5]) and the concomitant redistribution of the transporter in membrane microdomains ([@bib8]; [@bib32]), and inhibition of kinase-dependent phosphorylation of the transporter ([@bib10]; [@bib44], [@bib45], [@bib46]; [@bib29]) suppress the reverse transport mode (i.e., they do not impair substrate uptake but they blunt or eliminate amphetamine-induced release). The transport cycle of the mutant hSERT-ΔN32, for instance, has been subjected to a detailed kinetic analysis to understand the role of the N terminus of hSERT in inducing the kinetic switch between the forward-transport (i.e., uptake) and substrate-exchange (i.e., release) modes ([@bib18]). We simulated amphetamine-induced 5-HT release via hSERT-ΔN32 by reducing the transition rate of the substrate-loaded transporter between the inward- and outward-facing conformations (and vice versa; see reaction scheme in [Fig. 6](#fig6){ref-type="fig"}) from 100 to 8 s^−1^. The simulations yielded reduced 5-HT efflux ([Fig. 6 G](#fig6){ref-type="fig"}), but a normal turnover rate ([Fig. 6 H](#fig6){ref-type="fig"}); i.e., the simulations recapitulated the original experimental observations ([@bib18]).

Assessing substrate release by *p*-chloroamphetamine and PAL-1045 {#s18}
-----------------------------------------------------------------

Our model predicts a major difference in the Na^+^ dependence of the full releaser *p*-chloroamphetamine and of the partial releaser PAL-1045 ([Fig. 6 E](#fig6){ref-type="fig"}). We tested this prediction in HEK293 cells stably expressing SERT, which had been preloaded with \[^3^H\]MPP^+^. Because of its fixed charge, MPP^+^ does not permeate the cell membrane, and thus there is no confounding effect caused by background diffusion. The preloaded cells were superfused with buffer containing 100 µM ouabain starting 40 min before the application of the releasing compounds and throughout the experiment (see scheme in [Fig. 7 A](#fig7){ref-type="fig"}). Under these conditions, the internal Na^+^ concentration is expected to rise from ∼3 to ∼10 mM ([@bib13]). 2-min fractions of the superfusate were collected. The superfusion with ouabain did not cause any appreciable change in background release resulting in a straight baseline; this can be seen from the six 2-min fractions from 0 to 12 min in [Fig. 7 A](#fig7){ref-type="fig"} (the first 28 min of the superfusion with ouabain were omitted in [Fig. 7 A](#fig7){ref-type="fig"}). Addition of *p*-chloroamphetamine ([Fig. 7 A](#fig7){ref-type="fig"}, squares) caused a substantially larger release of \[^3^H\]MPP^+^ than PAL-1045 ([Fig. 7 A](#fig7){ref-type="fig"}, diamonds). This is consistent with the characterization of PAL-1045 as a partial releaser ([@bib35]). In [Fig. 7 B](#fig7){ref-type="fig"}, we show the calculated release rates in femtomole/minute/cell. These compare favorably with the rates predicted by the model ([Fig. 6 E](#fig6){ref-type="fig"}). In parallel, we exposed the cells to 10 µM monensin 10 min before the application of the releasers because this manipulation was predicted to raise the intracellular Na^+^ concentration by an additional 5 mM ([@bib11]). The synthetic data in [Fig. 6 E](#fig6){ref-type="fig"} predict that this additional increase in internal Na^+^ ought to enhance the releasing action of *p*-chloroamphetamine but not of PAL-1045. This prediction of the model was verified by the experimental observations; in the presence of monensin, *p*-chloroamphetamine caused a significantly larger efflux of \[^3^H\]MPP^+^ release ([Fig. 7 A](#fig7){ref-type="fig"}, circles and squares; [Fig. 7 B](#fig7){ref-type="fig"}, left bars). In contrast, efflux triggered by PAL-1045 was comparable in the absence and presence of monensin ([Fig. 7 A](#fig7){ref-type="fig"}, diamonds and triangles; [Fig. 7 B](#fig7){ref-type="fig"}, right bars).

![**Substrate release by *p*-chloroamphetamine and PAL-1045. (A)** Release of \[^3^H\]MPP^+^ from preloaded HEK293 cells expressing SERT. \[^3^H\]MPP^+^ release is plotted as percent \[^3^H\]MPP^+^ over time. The experimental conditions are indicated in the black bars: 3 µM *p*-chloroamphetamine (open squares), 3 µM *p*-chloroamphetamine + 10 µM monensin (open circles), 3 µM PAL-1045 (open diamonds), and 3 µM PAL-1045 + 10 µM monensin (open triangles). 100 µM ouabain (open bar) was present starting at t = −40 min and throughout the experiment. For statistical analysis, the total area under the curve after basal release (i.e., fractions t = 0 to t = 4 min) was calculated for each individual trace. \*\*, P \< 0.01; n.s., not significant. One-way ANOVA followed by Bonferroni's multiple comparison test. **(B)** Calculated \[^3^H\]MPP^+^ release rate for one cell in femtomole/minute (=*V~max~*). (A and B) Data are means ± SD, *n* = 8--9 independent observations per condition.](JGP_201711915_Fig7){#fig7}

Discussion {#s19}
==========

Amphetamines are known to induce the efflux of neurotransmitters via the plasmalemmal monoamine transporters. However, it has remained enigmatic whether they accomplish this by exploiting transport intermediate states, which exist under physiological conditions, or if additional, amphetamine-specific, conformational states are required ([@bib34]). The key conclusion of the present work is that additional transport mechanisms need not be invoked for a mechanistic explanation of amphetamine-induced monoamine release; the action of amphetamine is parsimoniously accounted for by the venerable alternating access model, provided that there is cooperative binding of substrate and cosubstrate. This conclusion is based on the following results: (a) Na^+^ increases substrate affinity, and the extent of this increase depends on the nature of the substrate ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). (b) In addition to positive cooperativity between Na^+^ and substrate binding, we show that K^+^, which selects the forward-transport over the substrate-exchange mode, accelerates substrate dissociation ([Fig. 4](#fig4){ref-type="fig"}). (c) A cooperative binding model, which only relies on physiological transport modes, can be derived from the present results and a diverse set of published electrophysiological and biochemical data. This model is, to the best of our knowledge, the first to account qualitatively and quantitatively for amphetamine-induced monoamine release ([Figs. 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). (d) The results described in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and subsequent simulations led to a prediction, which was directly verified in superfusion experiments: increasing the intracellular Na^+^ concentration enhanced amphetamine-induced substrate release in the case of *p*-chloroamphetamine, but not PAL-1045.

We relied on whole-cell patch-clamp electrophysiology to verify that SERT bound Na^+^ and substrate in a cooperative fashion. We tested cooperative binding between substrate and Na^+^ for the three high-affinity naphthyl-propan-amines PAL-287, PAL-1045, and PAL-1046. A sequential binding order, which assumes that substrate dissociation from outward open SERT precedes Na^+^ dissociation, predicts that a variation in extracellular Na^+^ does not have any effect on substrate dissociation. Our experimental results show that this is not the case. Hence, they refute a sequential binding order ([Fig. 1](#fig1){ref-type="fig"}). Rather, the present data and previous experiments ([@bib16]; [@bib2]) support the conjecture that Na^+^ increases the affinity of substrate and, importantly, that this effect depends on the nature of the substrate and on the side of titration (intracellular vs. extracellular Na^+^; [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). This is indicative of a random but cooperative binding order of substrate and Na^+^. At the current state, it is not possible to design experiments to address which of the two sodium ions binds cooperatively. Based on molecular dynamics simulations, Na^+^ bound to the Na2 site seems to be the logical candidate ([@bib33]).

A notable feature of cooperative substrate and cosubstrate binding is that it allows for direct competition between Na^+^ and K^+^ ([Fig. 5 A](#fig5){ref-type="fig"}), further corroborating the concept that mutually exclusive binding of these cations defines the kinetic decision point between the forward-transport and the substrate-exchange mode ([@bib14]). We tested whether K^+^ binding accelerated substrate dissociation. In previous experiments, it was not possible to directly test substrate dissociation because of its rapid kinetics ([@bib38]). However, the availability of the PAL series of substrates allowed us to overcome this obstacle ([@bib2]); the slow kinetics of PAL-1045 (∼0.025 s^−1^), in particular, provided an ideal dynamic range for identifying an interaction between substrate and K^+^. The experiment described here showed that K^+^ binding reduced substrate affinity for SERT ([Fig. 4](#fig4){ref-type="fig"}). Although we observed this effect at the outward-facing conformation, we infer that K^+^ also decreases substrate affinity at the inward-facing conformation. This inference is supported by the following experimental observations: (a) The PAL substrates showed equilibrium binding affinity in the nanomolar range when a K^+^-free solution with a high Na^+^ concentration was used. However, they displayed micromolar potency to inhibit substrate uptake (i.e., in the presence of high internal K^+^ concentrations). For instance, PAL-1045 displayed a 1,000-fold difference, as it showed a binding affinity of 4 nM but half-maximal uptake inhibition at 4 µM ([@bib2]). In the simulations, negative cooperativity between K^+^ and substrate was required to account for this discrepancy (see Appendix). (b) Dissociation of the PAL substrates from the inward-facing conformation is rate limiting for transporter turnover in the nominal absence of internal K^+^ and Na^+^; the dissociation rate further decreased with internal Na^+^ concentrations ([Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). However, in the presence of internal K^+^, their internal dissociation rates became indistinguishable from those of 5-HT and *p*-chloroamphetamine ([@bib2]). (c) K^+^ increased the dissociation rate of \[^125^I\]β-CIT (the binding site of which likely overlaps with the 5-HT--binding site) to a larger extent than a Na^+^-free solution (choline chloride; [@bib22]).

Furthermore, recent studies on LeuT indicated that K^+^ or H^+^ compete with Na^+^ ([@bib3]; [@bib20]), and molecular dynamics simulations on a homology model of hDAT suggested that a protonation of the conserved aspartate residue critical for substrate binding (D79 in hDAT and D98 in hSERT) facilitates dissociation of dopamine from the inward-facing conformation ([@bib7]). A ternary complex model predicts reciprocity of cooperative binding (i.e., substrate also increases Na^+^ affinity and decreases K^+^ affinity). It has been shown for several transporters, including LeuT, which is the bacterial homologue of the monoamine transporters ([@bib23]), that the binding affinities between the ion and substrate are codependent and that this dependence can vary among substrates ([@bib28]; [@bib48]; [@bib31]).

Most importantly, we show that a cooperative binding scheme is necessary to explain the actions of amphetamines on the monoamine transporters; amphetamine-induced dopamine release has been shown to increase with intracellular Na^+^ concentrations ([@bib21]; [@bib17]). This observation cannot be explained by a sequential binding model. If sodium and substrate were bound and released in a sequential order, high intracellular Na^+^ concentrations would impede the dissociation of substrate from the inward-facing conformation, thus precluding exchange of internal 5-HT for inwardly transported amphetamine; an alternative explanation invoked the formation of a substrate-conducting pore in response to amphetamine ([@bib17]). Although we cannot rule out the possibility that such a pore may occasionally be formed, we emphasize that our ability to account quantitatively for the experimentally observed release rates raises serious doubts about whether such a pore does indeed exist. The substrate-exchange mode is a property of any transporter that operates via alternating access. In contrast, the formation of a substrate pore is unrelated to the normal operating mode of transporters, which translocate substrates by undergoing a conformational cycle of alternating access. Thus, by definition, positing a substrate pore is not a parsimonious explanation because it is contingent on a major conformational change in the structure of the transporter. In contrast, our cooperative binding model does not require any deviation from the operating mode of a transporter. In fact, it is compatible with the available structural information and all known conformational states, which are visited during the transport cycle. Most of these are accessible by electrophysiological recordings ([@bib14]; [@bib2]; [@bib18]). We tested the cooperative binding model extensively in simulations; the resulting synthetic data recapitulated the experimental observations, regardless of whether they were obtained by electrophysiological recordings, by cellular uptake experiments or in radioligand binding experiments ([@bib14]; [@bib2]; [@bib18]). Therefore, a cooperative binding model, which is based exclusively on the physiological transport modes of SERT, is necessary and sufficient to reproduce the actions of amphetamines. Our experimental approach and consequently developed model are, however, unequipped for assessing entry and exit from intermediate states such as the substrate-loaded occluded state because these are currently not accessible to time-resolved kinetic analysis.

It has remained unclear how structural modifications ([@bib47]; [@bib18]), phosphorylation/dephosphorylation ([@bib10]; [@bib44], [@bib45], [@bib46]), palmitoylation ([@bib29]), lipid binding ([@bib5]), or association with proteins (e.g., flotillin; [@bib8]; [@bib32]) can have a profound impact on amphetamine-induced release without impinging on the forward-transport mode. This discrepancy is also observed in vivo; the behavioral effects of amphetamines are blunted by disrupting the phosphorylation of DAT or its interaction with flotillin1 in *Drosophila melanogaster* larvae ([@bib32]), or by reducing phosphatidylinositol-4,5-bisphosphate binding in adult *D. melanogaster* ([@bib12]). However, these manipulations do not affect behavioral readouts for the forward-transport mode (i.e., basal locomotion; [@bib12]) and the stimulatory action of the competitive DAT inhibitor methylphenidate ([@bib32]). It is currently not known how substrate release, but not uptake, can be selectively affected without violating the rules of microscopic reversibility. In addition, amphetamines were identified that display a reduced efficacy to induce monoamine release when compared with prototypical amphetamines. The cooperative binding model not only accounted for the releasing action of amphetamines, but it also provided explanations for how these phenomena occur ([Fig. 6](#fig6){ref-type="fig"}).

Appendix {#s20}
========

The kinetic model described here builds on previous models of DAT ([@bib9]) and SERT ([@bib6]; [@bib38]; [@bib36]; [@bib14]) with the important difference that it is the first to account for amphetamine-induced monoamine release. The kinetic parameters ([Fig. 5 A](#fig5){ref-type="fig"}) were derived from a series of electrophysiological, radioligand binding and uptake inhibition experiments. To reduce the complexity of the model, we used symmetric affinities for all substrates and cosubstrates at the outward- and inward-facing conformation and symmetrical transition rates between inward- and outward-facing states. Experimentally observed asymmetry, such as a lower apparent substrate affinity at the inward-facing conformation than at the outward-facing conformation, is a direct consequence of the cooperative binding mechanism (Na^+^ increases and K^+^ decreases substrate affinity, respectively). Note, however, that affinities of individual (co)substrates need not necessarily be symmetric ([@bib49]) as long as microscopic reversibility is maintained.

The parameters used in the model were derived from the experiments that follow.

Isomerization between inward- and outward-facing conformations {#s21}
--------------------------------------------------------------

### The substrate-loaded form {#s22}

The isomerization of the substrate-loaded outward-facing state to the substrate-loaded inward-facing state (100 s^−1^) was directly measured (see Fig. 4 in [@bib14]) and has been shown to be indistinguishable for all five substrates used in this study (see Fig. 3 in [@bib2]). We assigned this reaction a valence of 0.15 because it sufficiently recapitulated the voltage dependence of the transient peak current when a saturating internal Na^+^ concentration was used (see Figs. 3 A and 9 F(ii) in [@bib14]).

### The substrate-free K^+^-bound, substrate-free H^+^-bound, and substrate-free empty forms {#s23}

The return rates of the substrate-free transporter in a K^+^-bound, H^+^-bound, or empty form were directly measured and are shown in Fig. 6 in [@bib6], Figs. 1 and 5--8 in [@bib14], Figs. 5 and 6 in [@bib2], and in experiments shown in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} of this paper. The return of the substrate-free transporter to the outward-facing conformation is the rate-limiting reaction for the forward-transport mode and is voltage independent ([@bib26]; [@bib14]). Accordingly, we did not assign any valence to this reaction, but to the intracellular binding reactions of Na^+^, K^+^, and H^+^ (which will be described below).

Conducting state {#s24}
----------------

The conducting state (TiClK~cond~ or TiClH~cond~ in [Fig. 5 A](#fig5){ref-type="fig"}) of SERT is thought to be a Na^+^-conducting pore that is occasionally formed during the transport process. The parameters used to model this state are based on single-channel recordings by [@bib25], who reported channel lifetimes of ∼2--2.5 ms. This is incorporated in the model by the reaction from the open channel (TiClK~cond~ or TiClH~cond~) to the closed channel (TiClK or TiClH) at a rate of 500 s^−1^. [@bib25] calculated that the conducting state is occupied much less frequently than would be expected if it occurred during every transport cycle. The authors estimated that the open probability (P~o~) of the conducting state is \<10^−6^. In the model, we set the transition rate from the closed channel (TiClK or TiClH) to the open channel (TiClK~cond~ or TiClH~cond~) as 0.002 s^−1^ to account for the reported P~o~. The single-channel conductance of 2.4 pS used in the model was also adopted from [@bib25]. The conducting state was modeled to be in equilibrium with a K^+^- or H^+^-bound inward-facing conformation because the steady-state current was eliminated when internal K^+^ was omitted ([@bib38]; [@bib14]) but could be restored if internal H^+^ concentrations were raised to a pH of 5.5 (from pH 7.2; [@bib14]).

Substrate binding {#s25}
-----------------

The association rate constants of all five substrates to the outward-facing conformation have been directly measured by electrophysiological recordings (see Fig. 3 in [@bib2]) and were incorporated in the model. The dissociation rates and *α* values (cooperativity factors) were constrained by experiments described in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} of this paper and, in part, in Fig. 5 D in [@bib2].

Cation binding {#s26}
--------------

The rates of internal and external cation binding were inferred from a series of electrophysiological experiments ([Figs. 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [4](#fig4){ref-type="fig"}; [@bib14]; [@bib2]). Although direct measurements of cation-binding rates at the inward- and outward-facing conformation have not yet been possible, these experiments highly constrained the parameter space. Intracellular binding of the three cations Na^+^, K^+^, and H^+^ was assigned a valence of 1 because previous experiments showed that these reactions are highly voltage dependent ([@bib14]). The cooperative binding model reproduced the corresponding electrophysiological data; the voltage dependence of the peak current decreased with intracellular Na^+^ or K^+^ concentrations ([Fig. A1](#figA1){ref-type="fig"}; see Fig. 3 in [@bib14]).

![**Simulated current--voltage relationship of 5-HT--induced (10 µM) peak current.** Internal solutions containing (a) 0 M Na^+^/K^+^, (b) 0 M Na^+^/140 mM K^+^, and (c) 0 M K^+^/140 mM Na^+^ were used. The simulations reproduce experimental data described in [@bib14].](JGP_201711915_FigA1){#figA1}

### Na^+^ binding {#s27}

In the model, Na^+^ binding must display a rapid dissociation rate (\>100 s^−1^) because internal Na^+^ dissociation has been shown to carry the majority of the charge associated with the substrate-induced peak current ([@bib14]). However, the affinity must be sufficiently high to support stabilization of the outward-facing state by high external Na^+^ concentrations. Importantly, the increase of peak current recovery rates after 5-HT application by high internal Na^+^ concentrations could be simulated by both sequential binding ([@bib14]) and cooperative binding ([Fig. A2 A](#figA2){ref-type="fig"}), but not by a purely random binding order ([Fig. A2 B](#figA2){ref-type="fig"}).

![**Induction of the substrate-exchange mode requires cooperative binding**. **(A)** Simulated peak current recovery experiment using intracellular Na^+^ concentrations of 0 M or 140 mM using a cooperativity factor of 30. The time course of recovery after substrate application was modeled as the time course of return to ToClNa ([Fig. 5 A](#fig5){ref-type="fig"}). **(B)** Simulated peak current recovery experiment using intracellular Na^+^ concentrations of 0 M or 140 mM, but with a cooperativity factor of 1 (i.e., purely random order). The dashed curve reached steady state after 230 s (not depicted).](JGP_201711915_FigA2){#figA2}

### K^+^ binding {#s28}

There are two major constraints on the rates of K^+^ binding in the model: (1) K^+^ must dissociate rapidly from the outward-facing conformation to not be rate limiting for the forward-transport mode. (2) K^+^ must bind the inward-facing conformation rapidly to cancel out the electrogenicity of internal Na^+^ dissociation ([Fig. A1](#figA1){ref-type="fig"}; Fig. 3 in [@bib14]). Support for negative cooperativity of K^+^ binding in addition to the data shown in [Fig. 4](#fig4){ref-type="fig"} comes from the observation that the PAL substrates display micromolar potency to inhibit substrate uptake (a condition of high internal K^+^ concentrations) but displace the competitive inhibitor imipramine with nanomolar potency (a condition of high Na^+^ concentrations on both sides of the membrane; [@bib2]). This discrepancy could only be accounted for by negative cooperativity and was not observed using a random order ([Fig. A3, A and B](#figA3){ref-type="fig"}). In addition, a purely random order of K^+^ binding (i.e., an *ω* value of 1) did not recapitulate the low potency of internal 5-HT to inhibit the steady-state current ([Fig. A3 C](#figA3){ref-type="fig"}).

![**Negative cooperativity between substrate and K^+^. (A)** Simulation of radioligand binding at steady state. The simulations reproduce experimental data described in [@bib2]. The rates of imipramine binding were *k~on~*, 5 × 10^6^ M^−1^ s^−1^; *k~off~*, 0.015 s^−1^. **(B)** Simulation of uptake inhibition using different negative cooperativity factors (*ω* values). The simulation using an *ω* value of 200 reproduces experimental data described in [@bib2]. **(C)** Simulated 5-HT--induced currents.](JGP_201711915_FigA3){#figA3}

### H^+^ binding {#s29}

It has been shown that H^+^ ions can functionally replace K^+^ in supporting uptake and the steady-state current. The currently used (high) H^+^ affinity is constrained by the experiments described in [@bib14]. However, we note that this is very likely an overestimation because, for the sake of simplicity, sequential H^+^ binding was used.

Cl^−^ binding {#s30}
-------------

Elevating internal Cl^−^ concentrations increased substrate-induced inward currents in cut-open *Xenopus laevis* oocyte preparations ([@bib1]). Moreover, turnover rates were indistinguishable when Cl^−^ was increased from 0.5 to 143.5 mM in HEK293 cells using high internal K^+^/H^+^ concentrations (see Figs. 6--8 in [@bib14]). [@bib9] introduced a parsimonious explanation for a similar phenomenon in DAT and suggested that Cl^−^ stays bound to the transporter during the entire catalytic cycle. Accordingly, we introduced this principle in a previous model ([@bib14]) and kept it for the present model. The rates of Cl^−^ binding were chosen such that the experimental data could be reproduced; there was no direct measurement of Cl^−^ affinity. It is reasonable to assume a cooperative binding scheme like that of Na^+^ for Cl^−^ ([@bib16]), but this was not a subject of this study. The simulated turnover rate was independent of internal Cl^−^ concentrations ([Fig. A4](#figA4){ref-type="fig"}) and is thus consistent with electrophysiological results (see Figs. 6--8 in [@bib14]).

![**Turnover rates are independent of internal Cl^−^ concentration. (A)** Simulated peak current recovery experiment using 140 mM internal K^+^ and 0.5 mM internal Cl^−^. **(B)** Same protocol as in A, but using 152 mM internal Cl^−^. The simulations reproduce data described in [@bib14].](JGP_201711915_FigA4){#figA4}
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